Video Experimental Relacionado
Updated: Jun 24, 2026
08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Anticuerpos monoclonales para la inmunoterapia contra el cáncer
Louis M Weiner1, Madhav V Dhodapkar, Soldano Ferrone
1Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Lancet (London, England)
|March 24, 2009
Resumen
Los anticuerpos monoclonales pueden ser diseñados para estimular el sistema inmunológico contra el cáncer. Este enfoque mejora las respuestas inmunitarias antitumorales, lo que potencialmente mejora los resultados del tratamiento del cáncer.
Área de la Ciencia:
- Inmunología Inmunología.
- Oncología Oncología.
- Biotecnología La biotecnología es la biotecnología.
Sus antecedentes:
- Los anticuerpos monoclonales son terapias contra el cáncer establecidas.
- Su papel en la iniciación de respuestas inmunes específicas del tumor está poco explorado.
- La comprensión de estos mecanismos inmunes es crucial para el avance de la terapia de anticuerpos.
Objetivo del estudio:
- Presentar la lógica y la evidencia para desarrollar anticuerpos que estimulen las respuestas inmunes antitumorales del huésped.
- Explorar los mecanismos por los cuales los anticuerpos pueden mejorar la inmunidad contra el cáncer.
- Para resaltar las direcciones futuras para optimizar la inmunoterapia contra el cáncer basada en anticuerpos.
Principales métodos:
- Revisión de la literatura existente sobre los mecanismos de anticuerpos en el cáncer.
- Análisis de la citotoxicidad celular dependiente de anticuerpos (ADCC).
- Evaluación de la presentación cruzada de antígenos dirigidos a anticuerpos.
- La consideración de las interacciones de red idiotipicas.
Principales resultados:
- Los anticuerpos pueden inducir inmunidad antitumoral a través del ADCC.
- Los anticuerpos pueden promover la presentación cruzada de antígenos tumorales a las células T.
- La red idiotipica ofrece otra vía para la estimulación inmune.
- Estos mecanismos proporcionan una base para nuevas estrategias inmunoterapéuticas.
Conclusiones:
- La terapia de anticuerpos se puede mejorar aprovechando las respuestas inmunes específicas del antígeno tumoral.
- Las estrategias futuras deben centrarse en prolongar, amplificar y dar forma a estas respuestas inmunes.
- Los tratamientos optimizados de anticuerpos son prometedores para mejorar los resultados clínicos en el cáncer humano.
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...